Rapid Test System for the detection of Dengue NS1 Antigen and IgG/IgM antibodies to Dengue Virus in Human Serum/Plasma (DENGUCHECK COMBO )
- UID
- MFG/IVD/2020/000043_8c902253279df1365c6631035df12f7f_ccdac90104fb2edf9169897bb5e059a0
- Device class
- Class C
- Brand name
- CA 15-3
- Approving authority
- Sub Zonal Goa
- Product information
- Dengucheck Combo is intended for the detection of Dengue NS-1 antigen and IgG/IgM antibodies to Dengue virus. The test system can be used for screening of Dengue viral infection and as an aid for differential diagnosis of the self limiting primary Dengue infections and the potentially fatal secondary Dengue infections in conjunction with other criteria
Rapid Test System for the detection of Dengue NS1 Antigen and IgG/IgM antibodies to Dengue Virus in Human Serum/Plasma (DENGUCHECK COMBO ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000043_8c902253279df1365c6631035df12f7f_ccdac90104fb2edf9169897bb5e059a0. This device is marketed under the brand name CA 15-3. The license holder is ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is Sub Zonal Goa.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.